Vivos Therapeutics (VVOS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov20

Vivos Therapeutics released FY2025 Q3 earnings on November 19 After-Market EST, actual revenue USD 6.783 M (forecast USD 4.712 M), actual EPS USD -0.4925 (forecast USD -0.51)

00:00

Vivos Therapeutics released FY2025 9 Months earnings on November 19 After-Market (EST), actual revenue USD 13.62 M, actual EPS USD -1.4937

00:00

Aug19

Vivos Therapeutics released FY2025 Semi-Annual earnings on August 19 After-Market EST, actual revenue USD 6.835 M, actual EPS USD -1.0038

23:00

Vivos Therapeutics released FY2025 Q2 earnings on August 19 After-Market EST, actual revenue USD 3.82 M (forecast USD 3.365 M), actual EPS USD -0.5516 (forecast USD -0.38)

23:00

Jul1

Vivos Therapeutics' VIDASLEEP Receives CMS PDAC Approval

12:31

Jun26

Vivos Announces Release of OSA Treatment Results in European Pediatric Journal

13:44